Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    15276395 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Extended Dosing With Eltrombopag for Severe Aplastic Anemia
Condition: Severe Aplastic Anemia (SAA)
Intervention: Drug: Eltrombopag (promacta)
2 Active, not recruiting Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment
Conditions: Anemia, Aplastic;   Anemia, Hypoplastic
Interventions: Drug: h-ATG (ATGAM  );   Drug: Cyclosporine (Gengraf  )
3 Completed Telomere Repair Gene Mutation in Inflammatory Bowel Disease
Condition: Inflammatory Bowel Disease

Indicates status has not been verified in more than two years